12/10/2024
4:03 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:08 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:12 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:29 AM | Enanta Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
5:28 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:32 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:35 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/03/2024
5:37 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:41 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:01 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:03 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:04 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:06 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:08 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:10 PM | Enanta Pharmaceuticals (Issuer)
Kowalsky Matthew Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
7:35 AM | Enanta Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/25/2024
3:05 PM | Enanta Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:03 PM | ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/17/2024
3:31 PM | Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
08/09/2024
4:24 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:00 PM | Enanta Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
4:29 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
4:30 PM | Enanta Pharmaceuticals (Subject)
Rottinghaus Scott T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
7:38 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:15 PM | Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:19 PM | Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:12 PM | CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:31 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
12:11 PM | Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2024
7:21 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:23 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:00 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:09 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:12 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:15 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:18 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:26 PM | ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
11:15 PM | Enanta Pharmaceuticals (Filer)
| Form EFFECT | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
01/26/2024
8:11 AM | Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
4:23 PM | BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
11:25 AM | Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/11/2024
3:15 PM | Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
